Clavicle fractures, or broken collarbones, are typically treated without surgery. There is some evidence, though, to suggest that clavicle fractures may heal faster and more predictably when surgical ...

Paragon 28, Inc. (NYSE:FNA – Get Free Report) has earned a consensus rating of “Hold” from the six ratings firms that are presently covering the company, Ratings reports. Four research analysts have ...

Background The stress fracture of the fifth metatarsal bone (5MT) frequently occurs in youth soccer players in Japan, and it is very important issue to prevent this fracture. Objective To confirm ...

NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board of directors concerning the proposed ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

During the last three months, 5 analysts shared their evaluations of Paragon 28 (NYSE:FNA), revealing ... ankle procedures including ankle, Charcot, fracture fixation, hallux valgus, hammertoe ...

Fintel reports that on January 29, 2025, Needham downgraded their outlook for Paragon 28 (NYSE:FNA) from Buy to Hold. Analyst Price Forecast Suggests 12.46% Upside As of January 29, 2025 ...

Bengaluru: Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion ... while bolstering its fracture and trauma, and joint replacement businesses.

Analyst Price Forecast Suggests 21.83% Upside As of January 29, 2025, the average one-year price target for Paragon 28 is $14.62/share. The forecasts range from a low of $12.12 to a high of $21.00.